Business News Archives - Pendopharm https://pendopharm.com/news/category/business-news/ Wed, 20 Jul 2022 18:13:27 +0000 en-CA hourly 1 https://wordpress.org/?v=6.9 Health Canada Approves MYINFLATM (Colchicine 0.5 mg Extended-Release Tablets), a New Repurposed Treatment for Cardiovascular Disease https://pendopharm.com/news/health-canada-approves-myinflatm-colchicine-0-5-mg-extended-release-tablets-a-new-repurposed-treatment-for-cardiovascular-disease/ Fri, 27 Aug 2021 22:01:00 +0000 https://pendopharm.com/?p=1602 Pendopharm, a division of Pharmascience, is pleased to announce that Health Canada has issued a Notice of Compliance (NOC) approving MYINFLATM…

The post Health Canada Approves MYINFLA<sup>TM</sup> (Colchicine 0.5 mg Extended-Release Tablets), a New Repurposed Treatment for Cardiovascular Disease appeared first on Pendopharm.

]]> Pharmascience inc. contributes to the Montreal Heart Institute’s Colchicine Cardiovascular Outcome Trial (COLCOT) https://pendopharm.com/news/pharmascience-inc-contributes-to-the-montreal-heart-institutes-colchicine-cardiovascular-outcome-trial-colcot/ Sat, 16 Nov 2019 14:16:00 +0000 https://pendopharm.com/?p=1395 MONTREAL, November 16, 2019 – The Montreal Heart Institute (MHI) announced earlier today the results of its COLchicine Cardiovascular Outcomes Trial (COLCOT). This landmark…

The post Pharmascience inc. contributes to the Montreal Heart Institute’s Colchicine Cardiovascular Outcome Trial (COLCOT) appeared first on Pendopharm.

]]> PENDOPHARM, a division of PHARMASCIENCE INC wins the D.W. BOLE award https://pendopharm.com/news/pendopharm-a-division-of-pharmascience-inc-wins-the-d-w-bole-award/ Mon, 12 Nov 2018 21:54:00 +0000 https://pendopharm.com/?p=1196 On October 10, McKesson Canada hosted its 27th edition of the 2018 Distinction Awards Gala, with the theme Customizing our solutions…

The post PENDOPHARM, a division of PHARMASCIENCE INC wins the D.W. BOLE award appeared first on Pendopharm.

]]> PENDOPHARM a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals https://pendopharm.com/news/pendopharm-a-division-of-pharmascience-signs-an-agreement-with-cosmo-pharmaceuticals/ Tue, 20 Feb 2018 22:04:00 +0000 https://pendopharm.com/?p=1204 Montreal, February 19, 2018 – Pendopharm a division of Pharmascience Inc. signs an agreement with Cosmo Pharmaceuticals, an Irish specialty pharmaceutical…

The post PENDOPHARM a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals appeared first on Pendopharm.

]]> PENDOPHARM, a division of Pharmascience Inc., Invests in Ontario based Edesa Biotech and Licenses Three Novel Anorectal Treatments for Canada https://pendopharm.com/news/pendopharm-a-division-of-pharmascience-inc-invests-in-ontario-based-edesa-biotech-and-licenses-three-novel-anorectal-treatments-for-canada/ Fri, 22 Sep 2017 21:16:00 +0000 https://pendopharm.com/?p=1216 MONTREAL, Sept. 20, 2017 /CNW Telbec/ – Pendopharm, a division of Pharmascience Inc. announces today its investment in Ontario based Edesa…

The post PENDOPHARM, a division of Pharmascience Inc., Invests in Ontario based Edesa Biotech and Licenses Three Novel Anorectal Treatments for Canada appeared first on Pendopharm.

]]>